News Walvax Biotechnology Co., Ltd.

Equities

300142

CNE100000WN2

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
11.38 ^CNY	-.--%		-0.87%	-51.60%

26/06	Walvax Biotechnology Ends Vaccine Development Deal With Abogen Biotechnology	MT
18/06	Walvax Terminates Coronavirus Vaccine Trials Due to Mutations	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Walvax Biotechnology Ends Vaccine Development Deal With Abogen Biotechnology	26/06	MT
Walvax Terminates Coronavirus Vaccine Trials Due to Mutations	18/06	MT
Walvax Biotechnology Co., Ltd. Implements Final Cash Dividend for the Year 2023, Payable on 30 May 2024	23/05	CI
Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024	26/04	MT
Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial	25/04	MT
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04	CI
China's drugmakers can't sell mRNA shots but haven't quit yet	19/04	RE
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	03/04	CI
Walvax Biotechnology Co., Ltd.'s Equity Buyback announced on April 5, 2023, has expired with 2,000,000 shares, representing 0.12% for CNY 72.2 million.	03/04	CI
Walvax Biotechnology's 2023 Profit Falls 42%	02/04	MT
Walvax Biotechnology Co., Ltd. Proposes Cash Profit Distribution for 2023	02/04	CI
Walvax Biotechnology Scraps Plan to Issue Convertible Bonds	01/04	MT
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03	CI
Walvax Biotechnology Sees Up to 45% Drop in 2023 Profit	26/01	MT
Chinese Shares End Mixed as Stimulus Hopes Fade; Walvax Falls 6% on Downbeat Profit Outlook	26/01	MT
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China	11/01	MT
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	03/01	CI
Lanvin Group Chief Executive Joann Cheng Steps Down	08/12	MT
Walvax Biotechnology Registers Pneumonia Vaccines in Philippines	08/11	MT
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Walvax Biotechnology Co., Ltd.

Equities

300142

CNE100000WN2

Summary

Filters